Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
 | NOVO NORDISK | 13 | 40 | +0,49 % | |
| DANSKE BANK | 5 | 10 | -0,46 % | |
| DSV | 4 | 4 | -2,07 % | |
| VESTAS WIND SYSTEMS | 3 | 9 | -1,05 % | |
| CARLSBERG | 3 | 3 | +1,08 % | |
| ZEALAND PHARMA | 3 | 1 | -1,49 % | |
| ROYAL UNIBREW | 2 | - | -3,45 % | |
| AP MOELLER-MAERSK | - | 23 | +1,75 % | |
| ORSTED | - | 17 | +0,91 % | |
| BAVARIAN NORDIC | - | 7 | -0,24 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10:22 | Danske Bank bestätigt Jahresziele nach solidem erstem Quartal | 3 | Investing.com Deutsch | ||
| 10:15 | Dividendenbekanntmachungen (30.04.2026) | 861 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 4IMPRINT GROUP PLC GB0006640972 1,194 GBP 1,3782 EUR AB DYNAMICS PLC GB00B9GQVG73 0,0308 GBP 0,0355 EUR AGNC INVESTMENT CORP US00123Q1040 0... ► Artikel lesen | |
| 09:14 | NOVO NORDISK A/S im strategischen Gleichgewicht | 8 | Maximilian Berger | ||
| 09:12 | Danske Bank Sets 2028 Targets; Announces DKK 6.14/Share Special Dividend | 254 | AFX News | COPENHAGEN (dpa-AFX) - Danske Bank A/S (DNSKF) on Thursday announced an update to its Forward '28 strategy, including new financial targets for 2028, a revised dividend policy and an extraordinary... ► Artikel lesen | |
| 08:54 | Danske Bank A/S Q1 Sales Increase | 186 | AFX News | COPENHAGEN (dpa-AFX) - Danske Bank A/S (DNSKF) released earnings for first quarter of DKK5.686 billionThe company's bottom line totaled DKK5.686 billion, or DKK7.0 per share. This compares with... ► Artikel lesen | |
| 08:30 | DRINGEND: Novo nordisk: Könnte die Aktie jetzt komplett einbrechen? - Meine klare Einschätzung dazu | Hebelschein-Spekulant | |||
| 07:38 | Weight-Loss Injections, Cancer Cell Inhibitors & the Power of Algorithms: Adding Potential to Your Portfolio with Novo Nordisk, Vidac Pharma, and Evotec | 41 | The Market Herald Canada | ||
| 07:36 | Danske Bank A/S: Danske Bank announces financial targets for 2028 and an updated capital framework | 56 | GlobeNewswire (Europe) | Danske Bank announces financial targets for 2028 and an updated capital framework Danske Bank today announces an update to its Forward '28 strategy, including financial targets for 2028, a revised dividend... ► Artikel lesen | |
| 07:36 | Danske Bank A/S: Solid financial performance in the first quarter of 2026 driven by good customer activity, lending growth and strong credit quality Net profit of DKK 5.7 billion | 49 | GlobeNewswire (Europe) | Solid financial performance in the first quarter of 2026 driven by good customer activity, lending growth and strong credit qualityNet profit of DKK 5.7 billion Carsten Egeriis, Chief Executive Officer... ► Artikel lesen | |
| 05:34 | Abnehmspritze, Krebszellen-Stopp & Algorithmen-Power: Mit Novo Nordisk, Vidac Pharma und Evotec Potenzial ins Depot holen | 582 | Kapitalerhöhungen.de | Der Gesundheitsmarkt steht 2026 vor einem paradoxen Szenario. Öffentliche Kassen ächzen unter Rekordausgaben, während bahnbrechende Technologien die Medizin neu definieren. KI-gesteuerte Wirkstoffforschung... ► Artikel lesen | |
| Mi | Novo Nordisk: Denecimig (Mim8) significantly reduced annualized bleeding rate in people with hemophilia A, regardless of inhibitor status, in phase 3 data published in NEJM | 2.062 | PR Newswire | Published pivotal FRONTIER2 study showed investigational denecimig significantly reduced annualized bleeding rate compared to prior clotting factor prophylaxis and on-demand treatment in... ► Artikel lesen | |
| Mi | Zealand Pharma and Roche to advance weight loss drug to phase 3 | 7 | Investing.com | ||
| Mi | Zealand Pharma und Roche bringen Adipositas-Medikament in Phase-3-Studie | 12 | Investing.com Deutsch | ||
| Mi | Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management | 140 | GlobeNewswire (Europe) | Company announcement - No. 11 / 2026 Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management Phase 3 trials for chronic weight management... ► Artikel lesen | |
| Mi | Carlsberg Sees Sales Growth Through 2026 Even As Iran Crisis Looms | 5 | ESM Magazine | ||
| Mi | Royal UNIBREW A/S: Annual General Meeting 2026 | 189 | GlobeNewswire (Europe) | COMPANY ANNOUNCEMENT NO 22/2026 - April 29, 2026 On Wednesday, April 29, 2026, at 4 pm CEST Royal Unibrew A/S held its Annual General Meeting at which the below resolutions were made. Resolutions:... ► Artikel lesen | |
| Mi | Canada approves generic version of Novo's Ozempic | 13 | Seeking Alpha | ||
| Mi | JPMORGAN stuft NOVO NORDISK auf 'Neutral' | 730 | dpa-AFX-Analyser | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Novo Nordisk vor Zahlen auf "Neutral" mit einem Kursziel von 250 dänischen Kronen belassen. Richard Vosser verglich in einer... ► Artikel lesen | |
| Mi | Canada approves its first generic version of Novo's Ozempic | 10 | Financial Post | ||
| Mi | Vorteil auch für Versender: Lieferung: Keine Kühlkette für Wegovy | 23 | APOTHEKE ADHOC |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.